Please assess the completion status of the following clinical trial:

Trial Title: Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Postmenopausal women.~* Biopsy confirmation of primary breast cancer.~* Oestrogen receptor positive tumour.~* Fit for surgery within one month.~* Written informed consent to participate in the study~Exclusion Criteria:~* Previous treatment with any anti-hormonal therapy for breast cancer.~* Previous radiotherapy to the primary tumour.~* Previous chemotherapy for the primary tumour.

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Anastrozole Monotherapy
- 2 (Type: EXPERIMENTAL): Fulvestrant Monotherapy
- 3 (Type: EXPERIMENTAL): Anastrozole + Fulvestrant

Based on this trial design, predict the completion outcome and termination type (if applicable).